Evidence map›Paper›PMID 20064932›Full record

ArticleThe Journal of biological chemistry2010

Reversal of Xenopus Oct25 function by disruption of the POU domain structure.

Ying Cao, Franz Oswald, Stephan A Wacker, Karin Bundschu, Walter Knöchel

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Ying CaoInstitute of Biochemistry, University of Ulm, D-89081 Ulm, Germany.
Franz Oswald
Stephan A Wacker
Karin Bundschu
Walter Knöchel
Universität Ulm · DETechnische Hochschule Ulm · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Xenopus Oct25 is a POU family subclass V (POU-V) transcription factor with a distinct domain structure. To investigate the contribution of different domains to the function of Oct25, we have performed gain of function analyses. Deletions of the N- or C-terminal regions and of the Hox domain (except its nuclear localization signal) result in mutants being indistinguishable from the wild type protein in the suppression of genes promoting germ layer formation. Deletion of the complete POU domain generates a mutant that has no effect on embryogenesis. However, disruption of the alpha-helical structures in the POU domain, even by a single amino acid mutation, causes reversal of protein function. Overexpression of such mutants leads to dorsalization of embryos and formation of secondary axial structures. The underlying mechanism is an enhanced transcription of genes coding for antagonists of the ligands for ventralizing bone morphogenetic protein and Wnt pathways. Corresponding deletion mutants of Xenopus Oct60, Oct91, or mouse Oct4 also exhibit such a dominant-negative effect. Therefore, our results reveal that the integrity of the POU domain is crucial for the function of POU-V transcription factors in the regulation of genes that promote germ layer formation.

Indexed as

Gene Expression Regulation, DevelopmentalPOU Domain FactorsXenopus ProteinsActivinsAnimalsbeta CateninBone Morphogenetic Protein 4Cells, CulturedGene DeletionHumansKidneyMiceMutagenesisNodal ProteinNuclear Localization SignalsOctamer Transcription Factor-3Activinsbeta Cateninbmp4 protein, XenopusBone Morphogenetic Protein 4CTNNB1 protein, XenopusNodal ProteinNuclear Localization SignalsOctamer Transcription Factor-3Octamer Transcription Factor-6pou5f3.2 protein, XenopusPOU Domain FactorsT-Box Domain ProteinsVegT protein, XenopusXenopus Proteins

Identifiers

PMID20064932
PMCPMC2832990
OpenAlexW2033679697

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.